This is Snapshot #3 for FHIR R5, released to support Connectathon 32. For a full list of available versions, see the Directory of published versions.
Patient Care Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw XML (canonical form + also see XML Format Specification)
Example of conditiondefinition (id = "example")
<?xml version="1.0" encoding="UTF-8"?> <ConditionDefinition xmlns="http://hl7.org/fhir"> <id value="example"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative: ConditionDefinition</b> <a name="example"> </a> </p> <div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ConditionDefinition "example" </p> </div> <p> <b> url</b> : <code> http://hl7.org/fhir/ConditionDefinition/example</code> </p> <p> <b> identifier</b> : id: urn:oid:2.16.840.1.113883.4.642.25.1</p> <p> <b> name</b> : Hyperlipidemia</p> <p> <b> title</b> : Hyperlipidemia Status</p> <p> <b> status</b> : draft</p> <p> <b> date</b> : 2019-05-26T10:44:00+10:00</p> <p> <b> code</b> : Hyperlipidemia (disorder) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a> #55822004)</span> </p> <p> <b> hasSeverity</b> : false</p> <p> <b> hasBodySite</b> : false</p> <p> <b> hasStage</b> : false</p> <p> <b> definition</b> : <a href="https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol .pdf">https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol .pdf</a> </p> <blockquote> <p> <b> observation</b> </p> <p> <b> code</b> : Lipid Panel <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://loinc.org/">LOINC</a> #24331-1 "Lipid 1996 panel - Serum or Plasma")</span> </p> </blockquote> <blockquote> <p> <b> observation</b> </p> <p> <b> code</b> : Cholesterol <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://loinc.org/">LOINC</a> #35200-5 "Cholesterol [Moles/volume] in Serum or Plasma")</span> </p> </blockquote> <blockquote> <p> <b> observation</b> </p> <p> <b> code</b> : Triglyceride <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://loinc.org/">LOINC</a> #35217-9 "Triglyceride [Moles/volume] in Serum or Plasma")</span> </p> </blockquote> <blockquote> <p> <b> observation</b> </p> <p> <b> code</b> : Cholesterol in HDL <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://loinc.org/">LOINC</a> #2085-9 "HDL Cholesterol")</span> </p> </blockquote> <blockquote> <p> <b> observation</b> </p> <p> <b> code</b> : LDL Chol. (Calc) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://loinc.org/">LOINC</a> #13457-7 "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation")</span> </p> </blockquote> <h3> Medications</h3> <table class="grid"><tr> <td> -</td> <td> <b> Code</b> </td> </tr> <tr> <td> *</td> <td> Gemfibrozil <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/4.0.0/CodeSystem-v3-rxNorm.html">RxNorm</a> #203151)</span> </td> </tr> </table> <h3> Plans</h3> <table class="grid"><tr> <td> -</td> <td> <b> Reference</b> </td> </tr> <tr> <td> *</td> <td> <a href="broken-link.html">http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6</a> </td> </tr> </table> </div> </text> <url value="http://hl7.org/fhir/ConditionDefinition/example"/> <identifier> <system value="urn:ietf:rfc:3986"/> <value value="urn:oid:2.16.840.1.113883.4.642.25.1"/> </identifier> <name value="Hyperlipidemia"/> <title value="Hyperlipidemia Status"/> <status value="draft"/> <date value="2019-05-26T10:44:00+10:00"/> <code> <coding> <system value="http://snomed.info/sct"/> <code value="55822004"/> <display value="Hyperlipidemia (disorder)"/> </coding> </code> <hasSeverity value="false"/> <hasBodySite value="false"/> <hasStage value="false"/> <definition value="https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol .pdf"/> <observation> <code> <coding> <system value="http://loinc.org"/> <code value="24331-1"/> <display value="Lipid 1996 panel - Serum or Plasma"/> </coding> <text value="Lipid Panel"/> </code> </observation> <observation> <code> <coding> <system value="http://loinc.org"/> <code value="35200-5"/> <display value="Cholesterol [Moles/volume] in Serum or Plasma"/> </coding> <text value="Cholesterol"/> </code> </observation> <observation> <code> <coding> <system value="http://loinc.org"/> <code value="35217-9"/> <display value="Triglyceride [Moles/volume] in Serum or Plasma"/> </coding> <text value="Triglyceride"/> </code> </observation> <observation> <code> <coding> <system value="http://loinc.org"/> <code value="2085-9"/> <display value="HDL Cholesterol"/> </coding> <text value="Cholesterol in HDL"/> </code> </observation> <observation> <code> <coding> <system value="http://loinc.org"/> <code value="13457-7"/> <display value="Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation"/> </coding> <text value="LDL Chol. (Calc)"/> </code> </observation> <medication> <code> <coding> <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/> <code value="203151"/> <display value="Gemfibrozil"/> </coding> </code> </medication> <plan> <reference> <reference value="http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6"/> </reference> </plan> </ConditionDefinition>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR ®© HL7.org 2011+. FHIR R5 Ballot hl7.fhir.core#5.0.0-snapshot3 generated on Wed, Dec 14, 2022 07:16+1100.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R4B |
Compare to R5 Draft |
|
Propose a change